The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures. During the planning phase, the desired instrument placement and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data.
Publicado el 16 de octubre de 2024 · Inicio del retiro: 5 de agosto de 2024
Resumen
FDA registra el retiro Z-0037-2025 de dispositivos médicos de Clase II, publicado el 16 de octubre de 2024 e iniciado el 5 de agosto de 2024. Empresa responsable: QUANTUM SURGICAL SAS; Estado: Completado; Cantidad reportada: 2 units; Lote: UDI/DI 37603054002NGXL, serial numbers: 0321015 and 0321017. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Completed — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Quantum Surgical has become aware that a component (central axis) inside the Needle Guide product (product number 02-0027) is the subject of rust.
Qué hacer
Voluntary: Firm initiated · Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- QUANTUM SURGICAL SAS
- Distribuidor
- US Nationwide distribution in the state of FL.
- Lote
- UDI/DI 37603054002NGXL, serial numbers: 0321015 and 0321017
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- France
Retiros relacionados
- FDAEPIONE Model 30-0001 UDI-DI code: 03760305400031 The EPIONE® device is a user controlled, stereotactic18 de junio de 2025
- FDAPatient Information Center iX, Product Code 866386, and Patient Information Center iX Expand, Product Code16 de octubre de 2024
- FDA3M Tegaderm CHG, Chlorhexidine Gluconate I.V. Securement Dressing, REF 1658R16 de octubre de 2024
- FDAMEDLINE Automatic Digital Blood Pressure Monitor, REF MDS1001UT.16 de octubre de 2024
- FDAGE Healthcare Centricity Universal Viewer Zero Footprint Client, Model/Catalog/Code Numbers: a)¿¿¿¿¿16 de octubre de 2024
- FDAMEDLINE AUTOMATIC DIGITAL BLOOD PRESSURE UNIT, REF MDS1001U.16 de octubre de 2024
Preguntas sobre este retiro
¿The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures. During the planning phase, the desired instrument placement and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0037-2025 el 16 de octubre de 2024. Peligro reportado: Quantum Surgical has become aware that a component (central axis) inside the Needle Guide product (product number 02-0027) is the subject of rust.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Visit